10% Iron Isomaltoside 1000

DRUG2 trials

Sponsors

Pharmacosmos A/S, Pharmacosmos UK Ltd

Conditions

Iron Deficiency AnaemiaIron Deficiency Anemia

Unknown Phase

Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)

CompletedNCT01900197

Pharmacosmos A/SIron Deficiency Anemia

Start: 2013-08-31End: 2015-11-30Updated: 2016-03-02

Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)

CompletedNCT02546154

Pharmacosmos UK LtdIron Deficiency Anaemia

Start: 2016-01-22End: 2018-12-31Updated: 2019-05-23

Related Papers

NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease.

2020-12-1013 citations

The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency

Gastroenterology Research and Practice2017-01-0123 citations